COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥20 | CN¥20 | CN¥20 | CN¥24 |
| % Growth | -1.6% | 2.3% | -15.5% | – |
| Cost of Goods Sold | CN¥19 | CN¥20 | CN¥18 | CN¥21 |
| Gross Profit | CN¥1 | CN¥1 | CN¥2 | CN¥2 |
| % Margin | 5.7% | 2.9% | 10.4% | 10.3% |
| R&D Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| G&A Expenses | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| SG&A Expenses | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Sales & Mktg Exp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Other Operating Expenses | CN¥0 | CN¥0 | -CN¥0 | CN¥0 |
| Operating Expenses | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Operating Income | CN¥0 | -CN¥1 | CN¥1 | CN¥1 |
| % Margin | 0.4% | -2.8% | 6.8% | 5.8% |
| Other Income/Exp. Net | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Pre-Tax Income | CN¥0 | -CN¥1 | CN¥1 | CN¥1 |
| Tax Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Net Income | CN¥0 | -CN¥1 | CN¥1 | CN¥1 |
| % Margin | 0.1% | -3% | 5.3% | 4.8% |
| EPS | 0.014 | -0.327 | 0.57 | 0.605 |
| % Growth | 104.1% | -157.3% | -5.8% | – |
| EPS Diluted | 0.014 | -0.327 | 0.57 | 0.605 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Interest Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| EBITDA | CN¥1 | CN¥0 | CN¥2 | CN¥2 |
| % Margin | 3% | 0.2% | 9.9% | 9% |